Scarica l'app Stockscreener
0.6143
1.54%
0.0093
Dopo l'orario di chiusura:
.62
0.0057
+0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
Does Vistagen Therapeutics Inc. stock trade at a discount to peersEarnings Summary Report & Daily Profit Focused Stock Screening - mfd.ru
Bronstein, Gewirtz & Grossman LLC Urges Vistagen - GlobeNewswire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER - GlobeNewswire
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit - Financial Times
VTGN DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline - marketscreener.com
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline - GlobeNewswire Inc.
Notice of Class Action Lawsuit Against Vistagen Therapeutics - Intellectia AI
Total common shares outstanding of Vistagen Therapeutics, Inc. – BMV:VTGN - TradingView
Tangible book value per share of Vistagen Therapeutics, Inc. – BMV:VTGN - TradingView
UPCOMING DEADLINE: Vistagen Therapeutics, Inc. (VTGN) Securities Fraud Class ActionMarch 16, 2026 Lead Plaintiff Deadline - PR Newswire
Vistagen Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 16, 2026 to Discuss Your RightsVTGN - Finviz
LEVI & KORSINSKY, LLP: TIMELINE OF ALLEGED MISREPRESENTATIONS IN VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION (2026-03-04) - Seeking Alpha
VTGN Earnings History & Surprises | EPS & Revenue Results | VISTAGEN THERAPEUTICS INC (NASDAQ:VTGN) - ChartMill
Vistagen Therapeutics, Inc. Revenue Breakdown – BIVA:VTGN - TradingView
CapEx per share of Vistagen Therapeutics, Inc. – BIVA:VTGN - TradingView
Long term debt to total assets ratio of Vistagen Therapeutics, Inc. – BIVA:VTGN - TradingView
Basic earnings per share (basic EPS) of Vistagen Therapeutics, Inc. – BMV:VTGN - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTGN - ChartMill
The Gross Law Firm Notifies Vistagen Therapeutics, Inc. Investor - GuruFocus
Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors - GlobeNewswire
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - ChartMill
Vistagen to Participate in Upcoming Investor Conferences - marketscreener.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-03-03 | VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
Robbins LLP Reminds VTGN Stockholders of The March 16, 2026 Lead Plaintiff DeadlineContact The Firm Today For Information About Leading The Vistagen Therapeutics, Inc. Class Action - ACCESS Newswire
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, I - GuruFocus
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - PR Newswire
VISTAGEN THERAPEUTICS CLASS ACTION: LEVI & KORSINSKY, LLP EXPLAINS LEAD PLAINTIFF DEADLINE AND PROCESS - TipRanks
Shareholders that lost money on Vistagen Therapeutics, Inc. (VTGN) Urged to Join Class Action – ... - Bluefield Daily Telegraph
Shareholders that lost money on Vistagen Therapeutics, Inc. (VTGN) Urged to Join Class Action – Contact The Gross Law Firm to Learn More - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesVTGN - PR Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen - GlobeNewswire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline - marketscreener.com
2026-02-26 | VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
VTGN SEC FilingsVistagen Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vistagen Facing Class Action over Social Anxiety Disorder Drug Claims - TipRanks
VTGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
LEVI & KORSINSKY, LLP: UNDERSTANDING THE LEGAL FRAMEWORK FOR THE VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION - TipRanks
LEVI & KORSINSKY, LLP INVESTIGATING ALLEGED CLINICAL TRIAL DESIGN DEFICIENCIES AT VISTAGEN THERAPEUTICS -- CLASS ACTION FILED - PR Newswire
Vistagen CEO to give corporate overview at TD Cowen healthcare event - Stock Titan
Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis - Investing.com UK
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN) - marketscreener.com
Holzer & Holzer, LLC Reminds VTGN Investors of the March - GlobeNewswire
Aug Analyst Calls: Can Vistagen Therapeutics Inc sustain earnings growth2025 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Vistagen Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Vistagen - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
VistaGen (VTGN) Q3 2026 Earnings Call Transcript - AOL.com
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - PR Newswire
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):